Single-Dose Escalation Study of IDX184 in Healthy Volunteers (MK-2355-002)
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to obtain single dose safety and pharmacokinetic (PK) data of
IDX184 in humans. No formal hypotheses are to be tested in this study.